—

Hims Hers Health Inc (HIMS) — Technical state

As of 2026-11-03 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 37 out of 100 (momentum 38 · quality 32 · valuation 21), as of 2026-11-04.
  • Signal: Mixed moving-average stack — Trades -10.6% vs the 50-day and -4.7% vs the 200-day average, 46.8% below the 52-week high and +87% off the 52-week low; a golden cross printed 68 sessions ago. Computed from daily closes. (as of 2026-11-03)
  • Trend: Hims Hers Health Inc trades 10.6% below its 50-day and 4.7% below its 200-day moving average. (as of 2026-11-03)

Hims & Hers Health runs a direct-to-consumer platform that links patients online with licensed clinicians for prescription and over-the-counter care. It sells personalised treatments and products across skincare, hair care, sexual health, weight loss, hormone health and mental health, alongside lab testing that checks a range of body markers.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the HIMS overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Mixed moving-average stack

Trades -10.6% vs the 50-day and -4.7% vs the 200-day average, 46.8% below the 52-week high and +87% off the 52-week low; a golden cross printed 68 sessions ago. Computed from daily closes.

The moving-average stack

FAQ · from the current data · as of 2026-11-03

Quick answers

What is the current Closelooknet signal on HIMS?

Mixed moving-average stack — Trades -10.6% vs the 50-day and -4.7% vs the 200-day average, 46.8% below the 52-week high and +87% off the 52-week low; a golden cross printed 68 sessions ago. Computed from daily closes. As of 2026-11-03; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is HIMS above its 50-day and 200-day moving averages?

As of 2026-11-03, Hims Hers Health Inc trades -10.6% below its 50-day and -4.7% below its 200-day average, with the 20-day -9.9% away.

How far is HIMS from its 52-week high?

46.8% below the 52-week high and 87% above the 52-week low, as of 2026-11-03.

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.